Biohaven Announces Scientific Leadership Transitions

David Pirman, Ph.D. promoted to Executive Vice President and Head of Discovery Bruce Car, Ph.D. transitioning from Chief Scientific Officer to new role as Chief Innovation Officer focusing on external collaborations Warren Volles, General Counsel and Chief Legal Officer, also designated an executive officer David Pirman, Ph.D., has been promoted to Executive Vice President and Head of Discovery. In this role, Dr. Pirman will lead the Company's internal drug-discovery organization, overseeing research programs. Continue Reading Bruce D. Car, DVM, Ph.D., DACVP David Pirman, Ph.D. Warren Volles, J.D. Dr. Car is retiring as Chief Scientific Officer and will remain with the Company as a part-time employee in the newly created role of Chief Innovation Officer, effective July 13, 2026. In this role, Dr. Car will focus on advancing Biohaven's scientific initiatives and external collaborations including leading multiple assets under the Company's collaboration with Bexorg, Inc. Dr. Car will continue to serve as an executive officer of the Company. Warren Volles, General Counsel and Chief Legal Officer, has also been designated an executive officer of Biohaven and will continue to lead the Company's legal function. Vlad Coric, M.D., Chairman and Chief Executive Officer of Biohaven, said, "We thank Bruce as he has played a central role in building Biohaven's scientific foundation and helping translate discovery insights into multiple IND-stage programs across our portfolio. We are pleased that he will continue to bring his expertise to Biohaven in this new part-time role, with a particular focus on our collaboration with Bexorg. David's promotion reflects his leadership and significant contributions to Biohaven's discovery efforts, as well as his stron...